The Digital Therapeutics market in Israel is experiencing significant growth and development, particularly in the areas of Diabetes care, Mental & Behavioral health, Cardiovascular Health, and Musculoskeletal Health.
Customer preferences: In Israel, customers are increasingly seeking out digital therapeutics solutions that offer personalized and convenient options for managing their health conditions. With a tech-savvy population that values innovation and efficiency, there is a growing demand for digital tools that can provide effective support for various therapeutic areas.
Trends in the market: One notable trend in the Israeli Digital Therapeutics market is the integration of artificial intelligence and machine learning algorithms into digital health solutions. These technologies are being utilized to enhance the personalization and effectiveness of therapeutic interventions, leading to better health outcomes for patients. Additionally, there is a rising trend towards the use of mobile apps and wearable devices to deliver digital therapeutics, making it easier for individuals to access and engage with these solutions on a daily basis.
Local special circumstances: Israel is known for its strong focus on research and development in the healthcare sector, which has contributed to the emergence of innovative digital therapeutics products in the market. The country's robust startup ecosystem and supportive regulatory environment have also played a key role in fostering the growth of the Digital Therapeutics market. Moreover, Israel's culturally diverse population presents unique opportunities for companies to tailor their digital therapeutics offerings to meet the specific needs of different demographic groups.
Underlying macroeconomic factors: The increasing prevalence of chronic diseases in Israel, such as diabetes, cardiovascular conditions, and musculoskeletal disorders, has created a growing need for effective and accessible treatment options. Digital therapeutics have emerged as a promising solution to address these healthcare challenges by providing cost-effective and scalable interventions that can complement traditional medical treatments. Furthermore, the Israeli government's focus on promoting digital health innovation and adoption is driving investment and collaboration in the Digital Therapeutics market, paving the way for continued growth and advancement in the sector.
Data coverage:
The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.Modeling approach / Market size:
Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.Additional notes:
The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
